Comprehensive genomic analysis of Oesophageal Squamous Cell Carcinoma reveals clinical relevance. Issue 1 (December 2017)

• Record Type: Journal Article
• Authors: Du, Peina; Huang, Peide; Huang, Xuanlin; Li, Xiangchun; Feng, Zhimin; Li, Fengyu; Liang, Shaoguang; Song, Yongmei; Stenvang, Jan; Brünner, Nils; Yang, Huanming; Ou, Yunwei; Gao, Qiang; Li, Lin
• Is Part Of: Scientific reports. Volume 7:Issue 1(2017)
• Page Start: 1
• Page End: 9
• Publication Date: 2017-12
• Subjects: Natural history -- Research -- Periodicals; Biology -- Research -- Periodicals; Physical sciences -- Research -- Periodicals; Earth sciences -- Research -- Periodicals; Environmental sciences -- Research -- Periodicals; 502.85
• DOI: 10.1038/s41598-017-14909-5
• Languages: English
• ISSNs: 2045-2322

Abstract

Abstract Oesophageal carcinoma is the fourth leading cause of cancer-related death in China, and more than 90% of these tumours are oesophageal squamous cell carcinoma (ESCC). Although several ESCC genomic sequencing studies have identified mutated somatic genes, the number of samples in each study was relatively small, and the molecular basis of ESCC has not been fully elucidated. Here, we performed an integrated analysis of 490 tumours by combining the genomic data from 7 previous ESCC projects. We identified 18 significantly mutated genes (SMGs).PTEN, DCDC1 andCUL3 were first reported as SMGs in ESCC. Notably, theAJUBA mutations and mutational signature4 were significantly correlated with a poorer survival in patients with ESCC. Hierarchical clustering analysis of the copy number alteration (CNA) of cancer gene census (CGC) genes in ESCC patients revealed three subtypes, and subtype3 exhibited more CNAs and marked for worse prognosis compared with subtype2. Moreover, database annotation suggested that two significantly differential CNA genes (PIK3CA andFBXW7 ) between subtype3 and subtype2 may serve as therapeutic drug targets. This study has extended our knowledge of the genetic basis of ESCC and shed some light into the clinical relevance, which would help improve the therapy and prognosis of ESCC patients.